About
, brings six years of postgraduate specialty training to Specialized Clinic. He completed three years of Internal Medicine residency at Yale School of Medicine and Griffin Hospital, then went on to complete a three-year fellowship in Hematology and Oncology at East Carolina University. His clinical focus centers on novel targeted therapeutics for lung, breast, and genitourinary cancers, as well as hematologic conditions.
Dr. Baig stays closely engaged with emerging developments in oncology, pharmaceutical policy, and drug access. Away from the clinic, he enjoys grilling poolside with family and off-road adventures in his truck.
Education & Training
Residency
Internal Medicine, Yale School of Medicine and Griffin Hospital
Fellowship
Hematology & Oncology, East Carolina University
Conditions Treated
Who is Dr. Baig right for?
Dr. Baig is a strong fit for adults managing cancer diagnoses or hematologic conditions who want specialist-level oncology care integrated with their primary care team. Patients with lung, breast, or genitourinary cancers benefit from his focus on novel targeted therapies. He also suits patients who value a physician who keeps current with the latest developments in oncology and pharmaceutical access.
Similar Doctors Nearby
Frequently Asked Questions
Dr. Baig specializes in internal medicine and hematology and oncology. His clinical focus includes novel targeted therapeutics for lung, breast, and genitourinary cancers, as well as hematologic conditions.
Dr. Baig completed his three-year fellowship in Hematology and Oncology at East Carolina University. He completed his Internal Medicine residency at Yale School of Medicine and Griffin Hospital.
Dr. Baig has six years of postgraduate specialty training. He completed three years of Internal Medicine residency followed by three years of fellowship training in Hematology and Oncology.
Dr. Baig focuses on lung, breast, and genitourinary cancers, with a particular interest in novel targeted therapeutics. He also manages hematologic conditions.
Yes. Dr. Baig actively follows emerging research and developments in oncology, pharmaceutical access, and health policy. He contributes articles on topics including GLP-1 weight loss drugs, oncology devices, and pharmaceutical access through the practice newsroom.
Doctor profile last updated April 11, 2026